Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes.
S
S
Vadhan-Raj
W N
WN
Hittelman
J L
JL
Lepe-Zuniga
J U
JU
Gutterman
H E
HE
Broxmeyer
D000740:Anemia / Q000097:blood* / Q000150:complications; D003115:Colony-Stimulating Factors / Q000494:pharmacology / Q000627:therapeutic use; D004921:Erythropoietin / Q000097:blood* / Q000502:physiology; D006084:Graft Rejection / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000150:complications*
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D004921:Erythropoietin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor